By helping people limit compulsive eating and drinking, motivate movement, and reduce chronic inflammation, which we know GLP-1s can do, we promote a higher quality life. The latest science demonstrates that we should be thinking about GLP-1 medication differently, said Dr
Gut microbiome modulation Emerging evidence suggests berberine may alter intestinal bacterial composition, which could indirectly influence metabolic parameters
Dubbed a triple G medication, retatrutide is given once a week as an injection, just like its GLP-1 competitors
Back Gilbert, B, Rosenthal, D (21 Jan 2024) 'The complete history & strategy of Novo Nordisk: Novo Nordisk (Ozempic)', Acquired podcast, Season 14, Episode 1
10.1038/s41467-023-44067-4
This approach marks a significant step forward in the deliberate pursuit of targeting interconnected metabolic signals in concert